MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2337/dc20-0345

Медицинская библиотека · Diabetes care · 2020

Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study.

Gedebjerg Anne, Bjerre Mette, Kjaergaard Alisa Devedzic, Steffensen Rudi, Nielsen Jens Steen, Rungby Jørgen, Friborg Søren Gunnar, Brandslund Ivan, Thiel Steffen, Beck-Nielsen Henning, Sørensen Henrik Toft, Hansen Troels Krarup, Thomsen Reimar Wernich

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

Mannose-binding lectin (MBL) is linked to risk of cardiovascular disease (CVD) in diabetes, but the nature of the association is unclear. We investigated the association between MBL and the risk of cardiovascular events (CVE) and all-cause mortality in type 2 diabetes.

RESEARCH DESIGN AND

METHODS

In a cohort study of 7,588 patients with type 2 diabetes, we measured serum MBL in 7,305 patients and performed MBL expression genotyping in 3,043 patients. We grouped serum MBL and MBL expression genotypes into three categories: low, intermediate, and high. Outcomes were CVE (myocardial infarction, stroke, coronary revascularization, unstable angina, or cardiovascular death) and all-cause mortality. The association with outcomes was examined by spline and Cox regression analyses.

RESULTS

Serum MBL and CVE showed a U-shaped association. Compared with the intermediate serum MBL category, the adjusted hazard ratio (HR) for CVE was 1.82 (95% CI 1.34-2.46) for the low-MBL category and 1.48 (95% CI 1.14-1.92) for the high-MBL category. We found a similar U-shaped association for all-cause mortality, but with lower risk estimates. Compared with the intermediate MBL expression genotype, the adjusted HR for CVE was 1.40 (95% CI 0.87-2.25) for the low-expression genotype and 1.44 (95% CI 1.01-2.06) for the high-expression genotype. MBL expression genotype was not associated with all-cause mortality.

CONCLUSIONS

Both serum MBL and MBL expression genotype showed a U-shaped association with CVE risk in individuals with type 2 diabetes. Our findings suggest that serum MBL is a risk factor for CVD in this population.

Для цитирования: Gedebjerg Anne, Bjerre Mette, Kjaergaard Alisa Devedzic, Steffensen Rudi, Nielsen Jens Steen, Rungby Jørgen, Friborg Søren Gunnar, Brandslund Ivan, Thiel Steffen, Beck-Nielsen Henning, Sørensen Henrik Toft, Hansen Troels Krarup, Thomsen Reimar Wernich. Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study.. Diabetes care. 2020. DOI: 10.2337/dc20-0345.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.